Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
Type:
Grant
Filed:
January 25, 2019
Date of Patent:
December 1, 2020
Assignees:
BIOKINESIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Abstract: The present invention relates to compounds of formula (I) and pharmaceutical compositions comprising such compounds, for use for treating and/or preventing endometriosis.
Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
Type:
Grant
Filed:
May 4, 2017
Date of Patent:
January 29, 2019
Assignees:
BIOKINESIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
Type:
Grant
Filed:
December 6, 2013
Date of Patent:
May 9, 2017
Assignees:
BIOKINESIS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Abstract: The present invention relates to a new class of indole derivatives, having a particular MKlp2 inhibition profile and useful as a therapeutic agent, in particular for the treatment of cancer, viral infections and lung diseases.
Type:
Application
Filed:
December 6, 2013
Publication date:
October 29, 2015
Applicants:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, BIOKINESIS